4//SEC Filing
BIO-TECHNE Corp 4
Accession 0000914190-15-000299
$TECHCIK 0000842023operating
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:44 PM ET
Size
17.6 KB
Accession
0000914190-15-000299
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Gavin Robert M.
Sen. VP Protein Platforms
Transactions
- Award
Stock Option (Right to Buy)
2015-08-07+6,250→ 6,250 totalExercise: $108.49Exp: 2022-08-07→ Common Stock (6,250 underlying) - Award
Restricted Stock Units
2015-08-07+1,000→ 1,000 total→ Common Stock (1,000 underlying) - Award
Stock Option (Right to Buy)
2015-08-07+12,500→ 12,500 totalExercise: $108.49Exp: 2022-08-07→ Common Stock (12,500 underlying)
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $93.32Exp: 2021-07-31→ Common Stock (50,000 underlying) - 5,000
Restricted Stock Units
→ Common Stock (5,000 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $90.25Exp: 2021-11-30→ Common Stock (5,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $93.32Exp: 2021-07-31→ Common Stock (10,000 underlying)
Footnotes (7)
- [F1]2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
- [F2]The options vest if certain performance goals are achieved for calendar 2016.
- [F3]1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
- [F4]Vests in full or in part if certain performance goals are achieved for calendar 2016 (previously reported in Table I).
- [F5]3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- [F6]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F7]Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0000842023
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:44 PM ET
- Size
- 17.6 KB